Fonar Corp (FONR)
16.45
+1.56
(+10.48%)
USD |
NASDAQ |
Nov 21, 16:00
16.10
-0.35
(-2.13%)
Pre-Market: 20:00
Fonar Enterprise Value: 41.17M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 41.17M |
| November 20, 2024 | 31.18M |
| November 19, 2024 | 30.35M |
| November 18, 2024 | 31.06M |
| November 15, 2024 | 32.08M |
| November 14, 2024 | 35.02M |
| November 13, 2024 | 36.50M |
| November 12, 2024 | 34.70M |
| November 11, 2024 | 31.44M |
| November 08, 2024 | 32.08M |
| November 07, 2024 | 33.21M |
| November 06, 2024 | 34.63M |
| November 05, 2024 | 35.47M |
| November 04, 2024 | 29.48M |
| November 01, 2024 | 34.05M |
| October 31, 2024 | 33.66M |
| October 30, 2024 | 35.53M |
| October 29, 2024 | 34.31M |
| October 28, 2024 | 34.89M |
| October 25, 2024 | 33.79M |
| October 24, 2024 | 34.69M |
| October 23, 2024 | 35.79M |
| October 22, 2024 | 35.27M |
| October 21, 2024 | 35.14M |
| October 18, 2024 | 36.82M |
| Date | Value |
|---|---|
| October 17, 2024 | 36.69M |
| October 16, 2024 | 35.21M |
| October 15, 2024 | 36.49M |
| October 14, 2024 | 34.76M |
| October 11, 2024 | 33.66M |
| October 10, 2024 | 35.66M |
| October 09, 2024 | 37.52M |
| October 08, 2024 | 37.85M |
| October 07, 2024 | 39.20M |
| October 04, 2024 | 40.10M |
| October 03, 2024 | 38.17M |
| October 02, 2024 | 37.78M |
| October 01, 2024 | 37.85M |
| September 30, 2024 | 40.03M |
| September 27, 2024 | 47.50M |
| September 26, 2024 | 49.18M |
| September 25, 2024 | 47.69M |
| September 24, 2024 | 46.08M |
| September 23, 2024 | 45.63M |
| September 20, 2024 | 47.76M |
| September 19, 2024 | 46.79M |
| September 18, 2024 | 46.79M |
| September 17, 2024 | 47.76M |
| September 16, 2024 | 45.37M |
| September 13, 2024 | 43.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.56M
Minimum
Oct 25 2023
138.37M
Maximum
Aug 11 2020
68.38M
Average
64.85M
Median
Aug 19 2021
Enterprise Value Benchmarks
| XWELL Inc | 0.1013M |
| ProPhase Labs Inc | 35.22M |
| Applied DNA Sciences Inc | -8.969M |
| Veracyte Inc | 2.744B |
| OncoCyte Corp | 41.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.135M |
| Revenue (Quarterly) | 24.96M |
| Total Expenses (Quarterly) | 20.35M |
| EPS Diluted (Quarterly) | 0.46 |
| Gross Profit Margin (Quarterly) | 40.24% |
| Profit Margin (Quarterly) | 12.56% |
| Earnings Yield | 8.51% |
| Operating Earnings Yield | 13.75% |
| Normalized Earnings Yield | 6.788 |